A patient with cystic fibrosis. The HSE says that to date Orkambi had been ‘considered unjustifiably expensive’. File photograph: Science Photo Library

The HSE seems set to reject a “ground-breaking” but highly expensive drug for patients with cystic fibrosis in the public health system. The HSE said(...)

A patient with cystic fibrosis. The HSE is negotiating a price for the drug Orkambi for use in treatment of cystic fibrosis patients, Taoiseach Enda Kenny has said. File photograph: Science Photo Library

The HSE is negotiating a price for the drug Orkambi for use in treatment of cystic fibrosis (CF) patients, Taoiseach Enda Kenny has said. He said me(...)

Cystic fibrosis unit at St Vincent’s Hospital, Dublin. A ‘wonder drug’ used to treat adult cystic fibrosis patients has been rejected for use in a group of child patients.

A “wonder drug” used to treat adult cystic fibrosis patients has been rejected for use in a group of child patients after a study found it would cost (...)

Nivolumab  has been rejected on cost-effectiveness grounds for melanoma. Further assessment is ongoing for its use in kidney cancer

A cancer drug considered too expensive for the Irish health service has been found to significantly extend survival rates for patients with kidney can(...)

The #YesOrkambi campaign includes a video open letter to Taoiseach Enda Kenny and Minister for Health Simon Harris

Cystic fibrosis (CF) campaigns have launched a punchy social media campaign to persuade the Government to approve Orkambi, a drug that costs €160,000 (...)

For new, more expensive drugs to be approved for any illness, a cut in services must be made elsewhere in the system. And that, surely, merits a substantial national debate. File photograph: Getty Images

How do you put a price on a life? In a week when melanoma cancer patients were told the State would reimburse the costs of a new immunotherapy agent(...)

The reduction in the power of the Government is complemented by the rise of the power of the Dáil, and of the Opposition deputies in it.

O! What a beautiful morning! A little less beautiful today if you are a member of the new Government, though. There you are, settling in to your new(...)

Cystic fibrosis  campaigner said the decision to reject Orkambi  on cost effectiveness grounds was  disappointing.  Photograph: Alan Betson/The Irish Times

Cystic fibrosis patients have expressed disappointment after a “game-changing” drug was rejected on cost effectiveness grounds. Orkambi, which greatl(...)

Minister for Health Simon Harris asked for a report this week on the HSE deliberations on new cancer drugs. Photograph: Gareth Chaney/Collins

The HSE is expected to make a new cancer drug available free to patients with melanoma. Pembrolizumab should be included in the State drugs scheme fo(...)

Cystic Fibrosis Ireland said patients were dismayed by the recommendation against reimbursing the cost of the drug, Orkambi. Photograph: Getty Images

A new €160,000 drug that cystic fibrosis (CF) campaigners have described as a “game-changer” has been rejected for Irish patients on cost effectivenes(...)

  • « First
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »